Ephicacy
Ephicacy is a clinical biometrics CRO serving pharmaceutical, biotech, and medical device companies with data management, biostatistics, statistical programming, CDISC compliance, real-world evidence, and AI-enabled clinical data operations delivered globally across FSP, project-based, and consulting models.
- Company typePrivate
- Founded2005
- HeadquartersIselin, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Ephicacy does
Ephicacy is a privately held clinical biometrics Contract Research Organization (CRO) founded in 2005 in Iselin, NJ, by Ganesh Gopal. The company delivers end-to-end clinical data analytics services to pharmaceutical, biotechnology, and medical device companies across all phases of clinical trials, with stated experience spanning 100+ indications and 1,230+ projects. Its service portfolio is organized around three partnership models — Functional Service Provider (FSP), Project-Based Services, and Consulting — and covers data management, biostatistics, statistical programming (SAS and R), CDISC standards implementation, real-world evidence analytics, pharmacovigilance, medical device biometrics, and an emerging AI for Clinical Data Operations service line. Technology experience includes Spotfire, Tableau, Qlik, R Shiny, SAS, Python, AWS, Sycamore CDR/SCE, Databricks, and standards governance tooling such as Pinnacle21.
The company operates a hybrid onshore-offshore delivery model with offices in the United States, Canada, India (15+ years of operations as a Center of Excellence), and the United Kingdom, enabling 24/7 coverage and cost-effective scaling. Ephicacy holds CDISC Gold Member status, ISO 9001:2015, ISO/IEC 27001:2022, and ISO 22301:2019 certifications, and reports a 94% team retention rate among its 500+ in-house experts, supported by a 3,000+ programmer candidate database. Named enterprise clients include Merck, Bristol Myers Squibb, Pfizer, GSK, Novartis, and Eli Lilly.
Since 2022, Ephicacy has been backed by Great Point Partners, a healthcare-focused private equity firm, and in May 2024 acquired Advance Research Associates to expand biometrics and analytics capabilities. The company underwent a leadership transition in February 2025 with the appointment of Tara Gladwell (formerly President of Rho) as CEO while founder Ganesh Gopal moved to Chairman and President, followed by additional senior leadership additions including Board Director Névine Zariffa (June 2025), SVP of Biometrics Jamie Powers, and Head of India Operations Tyagrajan Swaminathan (March 2026).
Ephicacy firmographics
Firmographics- Name
- Ephicacy
- Legal name
- Ephicacy Corporation Limited
- Website
- https://ephicacy.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Ephicacy is a clinical biometrics CRO serving pharmaceutical, biotech, and medical device companies with data management, biostatistics, statistical programming, CDISC compliance, real-world evidence, and AI-enabled clinical data operations delivered globally across FSP, project-based, and consulting models.
- Ownership category
- akta.pro rank
Ephicacy industry classification
Industry- Product category
- Clinical Biometrics Contract Research Organization (CRO)
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Ephicacy is headquartered
LocationHeadquarters
- HQ city
- Iselin
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Ephicacy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Functional Service Provider (FSP) Model: Ongoing embedded support where Ephicacy provides dedicated resources that integrate into sponsor teams and operate under sponsor systems and SOPs. Offers scalability with ability to ramp resources up or down while maintaining oversight.
- Project-Based Services: Ephicacy takes full ownership of defined deliverables and timelines with dedicated teams for data managers, programmers, and statisticians. Milestone-based support with budget predictability.
- Clinical Development Consulting: Expert guidance at early planning stages including study design, regulatory interactions, and statistical modeling. Flexible hours and resource-on-demand model.
- Hybrid Models: Blending FSP and project-based models to provide support exactly where and how clients need it, accommodating multiple projects with varying support needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | FSP Model - Ongoing embedded support with scalable resources |
| Outcome Based/ Performance | Multi-year contract | Project-Based Model - Milestone-based delivery with defined deliverables |
| Other | Pay-as-you-go | Consulting Model - Expert guidance on demand |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Ephicacy product offering
Product offeringCore offering
Ephicacy is a niche Contract Research Organization (CRO) providing consulting and operational services in statistical programming, SDTM, ADaM, and clinical data management across all phases of clinical trials. It delivers biometrics, biostatistics, CDISC compliance, real-world evidence, pharmacovigilance, and AI-enabled clinical data operations to pharmaceutical, biotech, and medical device sponsors through FSP, project-based, and consulting engagement models.
Product overview
Ephicacy is a biometrics Contract Research Organization (CRO) offering a comprehensive suite of clinical data analytics services organized around three partnership models: Functional Service Provider (FSP), Project-Based Services, and Consulting. The core service portfolio includes Data Management (with sub-services Clinical Programming and Data Integration & Visualization), Biostatistics (with DMC Services), Statistical Programming (with CDISC Standards & Governance and R Programming sub-services), AI for Clinical Data Operations, Real-World Evidence & Observational Study Analytics, Pharmacovigilance (with Clinical Literature Review), Project Management, and Medical Device biometrics support. This is a services-based offering rather than a packaged software product, delivered through a global team across North America, India, and Europe with 24/7 coverage capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Data Management Comprehensive clinical trial data management services combining capacity and expertise through a global team with 24/7 coverage, including CRF design, EDC implementation, database design, data cleaning, query management, and medical coding. Includes Clinical Programming and Data Integration & Visualization sub-capabilities such as edit check reports, patient profiles, narratives, and lab reconciliation reports across EDC, labs, imaging, Spotfire, Tableau, Qlik, R Shiny, AWS, and Databricks platforms. Intended for pharmaceutical, biotech, and medical device sponsors running clinical trials.
- Biostatistics Real-world and clinical biostatistics services including statistical design, conduct, monitoring, and reporting, plus protocol input, sample size calculations, SAP development, Tables/Listings/Figures (TLFs), CSR development, publications, and Data Monitoring Committee (DMC) support. Includes dedicated DMC services with unblinded output generation across oncology, neuroscience, cardiovascular, and other therapeutic areas. Intended for pharmaceutical and biotech sponsors.
- Statistical Programming End-to-end statistical programming support including CDISC-compliant SDTM and ADaM dataset programming, TLF production, submission-ready SAS and R programming, ISS/ISE programming, and eSUB package preparation for regulatory submissions. Includes CDISC Standards & Governance (CDASH/SDTM/ADaM mapping, Pinnacle21 validation, eCTD submission packages, define.xml generation) and R Programming (R Shiny dashboards, custom packages, SAS-to-R migration, validated production environments). Programmers average 5+ years of CDISC experience. Intended for clinical trial sponsors requiring regulatory submission-ready datasets.
- AI for Clinical Data Operations AI adoption strategy and tools for clinical data operations including TLF (Tables, Listings, Figures) automation, CSR drafting accelerators, SAS-to-R code migration assistance, data review assistant for anomaly surfacing, clinical literature review copilots, and protocol-to-SAP mappers. Includes governance and validation playbooks and AI training programs. Teams adopting these tools have realized cost reductions up to 30% and target less than 1% error rates in automated steps under defined controls. Intended for clinical development teams seeking efficiency gains in regulated biometrics workflows.
- Real-World Evidence & Observational Study Analytics Real-world evidence analytics services including evidence strategy, data source acquisition from claims/EHR/pharmacy/registries/labs/PRO, data standardization to OMOP, HL7 FHIR, and CDISC, comparative effectiveness analysis, external control arms, treatment pattern analytics, and visualization for submissions. Source-agnostic data strategy intended for pharmaceutical and biotech sponsors pursuing regulatory submissions with real-world data.
- Pharmacovigilance Pharmacovigilance services for detecting, analyzing, and reporting safety signals including safety data analytics, clinical literature review with weekly multilingual monitoring and AI-enabled screening (37,900+ articles screened), signal detection, and regulatory document support (Investigator Brochure, Risk Management Plan, PBRER), plus gap analysis. Intended for pharmaceutical sponsors requiring ongoing drug safety monitoring.
- Project Management Strategic project management for clinical data operations delivered as a consulting service or as part of FSP and project-based delivery models, providing coordination across technical, operational, and financial dimensions. Intended for clinical trial sponsors requiring outsourced program leadership.
- Medical Device Biometrics Specialized biometrics support for medical device, diagnostic, and combination-product trials including clinical trial design, IDE strategy, clinical event adjudication, DMC support, database design for dense data capture, complex randomization, and FDA engagement support. Includes 300+ device programs supported and 100+ successful regulatory submissions for medical device programs. Intended for medical device and diagnostic companies.
- Functional Service Provider (FSP) Partnership Model Flexible FSP engagement model offering dedicated functional expertise, scalable resourcing, sponsor-aligned delivery under sponsor processes, SOPs, and systems, and continuity for long-term partnership. Ring-fenced resources embedded within sponsor teams with ability to ramp up or down. Multi-year contract pricing. Intended for enterprise pharma sponsors with ongoing biometrics resourcing needs.
- Project-Based Services Partnership Model Project-based service model with end-to-end delivery ownership where Ephicacy takes full accountability for defined deliverables, timelines, and outcomes with milestone-based support and established budgets. Rapid onboarding and hands-on custom solutions. Multi-year contract pricing. Intended for midsize pharma, biotech, and medical device sponsors with project-scoped biometrics needs.
- Clinical Development Consulting Clinical development consulting providing early-stage strategic guidance including study design optimization, regulatory authority interaction guidance, statistical modeling, standardized data flows, and CDISC compliance implementation. Flexible hours and resource-on-demand model with pay-as-you-go billing. Intended for emerging biotech and small pharma with limited internal biometrics resources.
Quantifiable outcome
- 94% team retention rate ensuring client programs work with experienced professionals who know their programs
- +5 more outcomes
Companies that use Ephicacy
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Ephicacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability12 records
Feature5 records
Ephicacy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Advance Research AssociatesmajorEphicacy Consulting Group completed the acquisition of Advance Research Associates in May 2024, expanding its biometrics and analytics capabilities.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Ephicacy competitors and assessment
Company assessmentBroad incumbents
- Fortrea (formerly LabCorp Drug Development): Fortrea is a global CRO spun out of LabCorp in 2023 offering clinical and biometrics services. Broad incumbent with biometrics overlap; competes against Ephicacy on FSP and biometrics outsourcing bids.
- IQVIA: IQVIA is the largest global full-service CRO with deep biometrics and RWE capabilities through its Quintiles heritage. Ephicacy's Jamie Powers previously worked at IQVIA. Broader incumbent offering overlapping biometrics but as part of a much wider portfolio.
- Parexel International: Parexel is a major global full-service CRO with biometrics and biostatistics capabilities. Broad incumbent overlapping with Ephicacy in CDISC, statistical programming and biostatistics but as part of an end-to-end clinical offering.
- ICON plc: ICON plc is a top-tier global CRO with full clinical and biometrics services following the PRA Health Sciences merger. Broad incumbent competing with Ephicacy on biometrics within larger full-service deals, especially with large pharma.
Direct peers
- Cytel: Cytel is a specialty biometrics CRO with deep biostatistics and statistical programming capabilities serving global pharma and biotech. Directly comparable in services (statistical programming, CDISC, biostatistics) and therapeutic-area focus, with overlapping FSP and consulting delivery models.
- Phastar: Phastar is a specialist biometrics CRO offering data management, biostatistics, statistical programming and CDISC services to pharma and biotech globally. Direct peer in niche biometrics with global delivery model and similar mid-market positioning to Ephicacy.
- Veramed: Veramed is a biometrics CRO specializing in biostatistics and statistical programming for pharma and biotech. Direct comparable with similar service portfolio, mid-tier customer mix, and biostatistics/statistical programming as primary offerings.
- Rho: Rho is a US-based biometrics-focused CRO offering data management, biostatistics, statistical programming and regulatory services to pharma and biotech. Highly comparable: Ephicacy's new CEO Tara Gladwell came directly from Rho as President, and the two firms compete head-to-head in mid-market biometrics outsourcing.
Emerging players
- Precision for Medicine: Precision for Medicine is a CRO specializing in biomarker-driven and precision medicine trials, with biometrics and biostatistics capabilities. Emerging peer with strong overlap in specialty/biomarker-enabled clinical analytics and RWE work relevant to Ephicacy's RWE and specialty therapeutic services.
- Clario: Clario is a clinical trial technology and endpoint services company with biometrics integration and eCOA/ePRO strengths. Partially overlapping with Ephicacy's data management and clinical data integration services, particularly around EDC, clinical data review and AI-enabled workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Ephicacy social profiles
Digital presenceEphicacy compliance and trust
Trust signalCompliance3 records
Ephicacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ephicacy leadership team
Management profileNumber of profiles
Profiles12 records
Ephicacy subsidiaries and ownership
Company hierarchySubsidiaries1 record
Ephicacy funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ephicacy M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ephicacy
What does Ephicacy do?
Ephicacy is a niche Contract Research Organization (CRO) providing consulting and operational services in statistical programming, SDTM, ADaM, and clinical data management across all phases of clinical trials. It delivers biometrics, biostatistics, CDISC compliance, real-world evidence, pharmacovigilance, and AI-enabled clinical data operations to pharmaceutical, biotech, and medical device sponsors through FSP, project-based, and consulting engagement models.
Is Ephicacy a public or private company?
Ephicacy is a private company. It is classified as private equity controlled and is currently operating.
When was Ephicacy founded?
Ephicacy was founded in 2005. It employs 251 to 500 people.
Where is Ephicacy based?
Ephicacy is headquartered in Iselin, United States, in the North America region.
How does Ephicacy make money?
Four revenue lines are on record. Functional Service Provider (FSP) Model is the primary driver. The others are project-Based Services, clinical Development Consulting and hybrid Models.
Who are Ephicacy's main competitors?
Broad incumbents on record are Fortrea (formerly LabCorp Drug Development), IQVIA, Parexel International and ICON plc. Direct peers are Cytel, Phastar, Veramed and Rho. Emerging players are Precision for Medicine and Clario.
Does Ephicacy have an API?
No public API is recorded for Ephicacy.
What industry is Ephicacy in?
Ephicacy's product category is Clinical Biometrics Contract Research Organization (CRO). Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.